Rhythm Pharmaceuticals, Inc.
Clinical trials sponsored by Rhythm Pharmaceuticals, Inc., explained in plain language.
-
Promising drug targets severe weight gain from brain damage
Disease control Recruiting nowThis study tests a daily injection called setmelanotide to help people aged 4 and older who have severe obesity due to a brain condition (hypothalamic obesity). Participants receive either the drug or a placebo for 26 weeks. The goal is to see if it reduces weight, hunger, and im…
Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 06:19 UTC
-
New weekly shot hopes to tame genetic obesity
Disease control Recruiting nowThis study tests a new weekly injection called RM-718 in people with obesity, including those with a genetic condition affecting the MC4R pathway (like Prader-Willi syndrome). The main goal is to check the drug's safety and how the body processes it. About 150 participants will t…
Phase: PHASE1, PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC